RT Journal Article
SR Electronic
T1 792 Givastomig, a novel Claudin18.2/4–1BB bispecific antibody, exerts bystander tumor-killing and synergistic anti-tumor activity with therapeutics in 1L/2L treatment for gastric cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A889
OP A889
DO 10.1136/jitc-2023-SITC2023.0792
VO 11
IS Suppl 1
A1 Liu, Xuejun
A1 Xu, Ke
A1 Meng, Jane
A1 Xia, Jie
A1 Pan, Chenyu
A1 Li, Ao
A1 Li, Zhenhu
A1 Wang, Zhengyi
A1 Jung, Jaeho
A1 Zhu, Andrew
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A889.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.